RenovaCare
Technology: CellMist systems with SkinGun
CEO: Thomas Bold
Website: renovacareinc.com
RenovaCare’s flagship CellMist system has 2 components: The CellMist solution, a water-based solution with the patient’s own stem cells; and the SkinGun, an ultra-gentle spray device which deposits the CellMist solution. The technology offers an alternative to conventional skin graft surgery, which can be painful, prone to complications and slow to heal.
A small sample of the patient’s healthy skin is processed to liberate the stem cells from surrounding tissue. The cells are suspended in a water-based solution, placed into a syringe which is attached to the SkinGun. Within 90 minutes of a patient arriving in an emergency room, stem cells are isolated, processed and sprayed onto the wound site.
A wound heals from the edges to the middle, and the longer that takes, the higher is the risk for inflammation and finally scarring. CellMist creates thousands of little regenerative islands all over the wound. These islands connect to each other to heal the wound, resulting in skin that looks and functions as it did before.
CellMist is under investigational use in Europe and the United States.
7 companies in the race to make an artificial pancreas>>
|
juan ernesto says
November 15, 2017 at 5:18 pmHeather, great insights on the changing needs for medtech start-ups. We were thrilled to see, Madorra, one of our collaborating partners make your top 10. Look forward to following your updates on this incredible startup space.
Heather Thompson says
November 15, 2017 at 6:33 pmThey are doing some important work. Thanks, Juan. I’m excited to see the latest crop of startups for 2018 as well.